FANCD2 Antibodies

Santa Cruz Biotechnology features a diverse variety of FANCD2 monoclonal antibodies for investigating FANCD2 protein's role in DNA repair and cellular response to genotoxic stress. FANCD2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FANCD2 is a crucial component of the Fanconi anemia (FA) pathway, which is essential for the repair of DNA interstrand cross-links and maintaining genomic stability. Mutations in the FANCD2 gene can lead to Fanconi anemia, a genetic disorder characterized by increased cancer susceptibility and bone marrow failure. Understanding FANCD2 function is vital for elucidating the mechanisms of DNA repair and the implications of its dysfunction in cancer biology. FANCD2 monoclonal antibodies enable precise detection and analysis of protein expression, localization, and interactions in various experimental settings. Researchers can utilize FANCD2 monoclonal antibodies to examine protein modifications, complex formation, and cellular distribution patterns. FANCD2 monoclonal antibodies support cutting-edge research in DNA repair pathways, cancer biology, and genetic disorders. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific understanding of cellular mechanisms and disease processes through reliable and specific detection methods.